AIIMS Bhubaneswar PERFUSE-AKI Recruitment 2026: 3 Research and Technical Support Vacancies

# AIIMS Bhubaneswar PERFUSE-AKI INDIA: 3 Project Research and Technical Support Vacancies (2026)

AIIMS Bhubaneswar has invited applications by email, not through a public online application portal, for three six-month ICMR-funded positions in its PERFUSE-AKI INDIA multicentre critical-care trial: one Project Research Scientist-II (Non-Medical) and two Project Technical Support-II vacancies. Two different essential eligibility pathways apply to the scientist position, whereas the technical-support position expressly requires a Science Class 12 qualification, relevant MLT/DMLT diploma and five years of experience. The deadline for the prescribed-format email is 23 October 2026 at 5:00 PM IST. The walk-in interview on 27 October is tentative. Candidates should choose a position based on the actual essential route, not the job title alone.

## What this specific October notice covers, and what it does not

The 13 October 2026 advertisement identifies E-File AIIMS/BBSR/ANAES/569, the Department of Anaesthesiology and Critical Care and principal investigator Dr Prasanta Kumar Das. Its vacancy table has **one Scientist-II and two PTS-II seats**, or three appointments in total. No UR/OBC/SC/ST/EWS vertical breakup is published. The 31 October MoES marine-bivalve Project Associate I recruitment and the separate October sickle-cell Transfusion Medicine recruitment have different investigators, qualifications and email destinations; they are not posts under this PERFUSE-AKI advertisement. The separate Transfusion Medicine vacancy is covered by a different notification and requires its own application; it cannot be applied for through the PERFUSE-AKI principal investigator.

## Scientist-II has a PhD alternative: do not turn the PG experience rule into a universal condition

The exact **essential** wording is a postgraduate degree (including integrated PG) in Life Sciences or Public Health **with three years of post-qualification experience, OR a PhD**. Accordingly, an applicant who relies on the PG route needs three properly evidenced years after obtaining that qualifying credential. An applicant relying on the PhD alternative should not be automatically rejected for lacking those three PG-route years: the notice places PhD after an OR. A PhD holder still needs to demonstrate relevance and all other notified conditions; the institute decides equivalence and suitability. It does not specify a universal MBBS, BTech, DMLT, NET, age 18 or minimum academic percentage. Do not transplant the other PTS-II vacancy's 5-year duration into Scientist-II.

## Desirable research methods are selection differentiators, not mandatory additional degrees

The Scientist-II desirable column refers to experience in clinical research and preferably multicentre critical-care trials, manuscript/report writing, research methodology, GCP, research ethics, CTRI and SOP documentation, monitoring, analytical software (R/STATA/SPSS) and REDCap eCRF development. These named competencies help a qualifying applicant explain the relevance of past work and create a project-specific evidence portfolio. They are not all separate essential pass/fail credentials. An applicant with a verified PhD and strong clinical trial data-management experience should describe actual tasks performed and tools used, rather than merely listing software certificates. No employer-published specific examination syllabus, research-paper minimum or number of publications appears in the notice.

## PTS-II: the 5 years attach to a Science 12th plus technical diploma route

The PTS-II table states **12th pass in Science subjects + Diploma in MLT/DMLT (or equivalent) + five years' experience**. It is not a generic degree-only post: neither Science 12th alone nor a diploma without the experience satisfies the complete published route. Do not rely on an unofficial degree-based alternative unless AIIMS issues a corrigendum. The institute stipulates relevant-field post-minimum-qualification experience. A candidate should have date-bounded experience certificates with laboratory/research coordination duties, not simply a current employment letter. Desirable prior coordination of clinical trials and facility with Excel, Word, PowerPoint and electronic documentation strengthen an application but do not displace the essential diploma and experience.

## Age is anchored to 23 October, not to the tentative 27 October walk-in

The maximum advertised age is **40** for Scientist-II and **30** for PTS-II. Clause 9 expressly calculates age on the **last application-submission date**, 23 October 2026. The tentative 27 October interview is therefore not the age reference date for either role. SC/ST/OBC/PWD relaxations are said to follow government rules, but this PDF supplies no quantified years; applicants should verify applicable eligibility with the institute instead of assuming a precise additional period. Neither post has a separately advertised minimum age.

## Pay and the six-month term: distinguish the base amount from the HRA component

Scientist-II carries **Rs 67,000 consolidated per month PLUS 20% HRA**, and PTS-II **Rs 20,000 consolidated per month PLUS 20% HRA**. The arithmetic HRA component would be Rs 13,400 and Rs 4,000 respectively if payable exactly as advertised, with combined components of Rs 80,400 and Rs 24,000 before any deductions. These are remuneration components, **not an official guarantee of net/in-hand salary**, a regular 7th CPC permanent scale or an automatic allowance entitlement beyond the exact written terms. The initial tenure of **six months** applies to both roles; continuation is conditional on need, performance and approval, not guaranteed.

## Email-before-walk-in is a gate, and the emails cannot be interchanged

Send the completed **prescribed Annexure application** to **anaes_prasanta@aiimsbhubaneswar.edu.in** no later than **23 October 2026 at 17:00 IST**. Use the subject **Application for the post of [exact post title]**. A candidate applying for both grades must send a **separate application for each post**. The current PDF specifically states that **no hard copy is required at the initial email stage**. Shortlisted applicants must bring the completed form, original certificates, self-attested copies and passport photograph to the offline walk-in, tentatively on **27 October**, with a listed **10:00 AM** reporting time in Seminar Room 153, first floor, Department of Anaesthesiology and Critical Care, Hospital Building near PAC Clinic. The 27 October date is explicitly tentative; confirmation must be checked with AIIMS before travel. The other 23 October Transfusion Medicine recruitment uses a different email; sending both to one project investigator is a material submission risk.

## Who should avoid applying and what happens after selection

The notice explicitly excludes persons **already in regular time-scale service under any Government department/organisation**. These are purely temporary project contracts and confer no right to a permanent AIIMS, funding-agency or other government post. The advertisement excludes pension, provident-fund, LTC and medical-claim benefits specified for regular service. Original qualification, age, experience and identity proofs are mandatory for joining verification; deficiencies or contradictions can mean the seat is offered to a waitlisted candidate. The employee cannot treat a payment in lieu of notice as an unconditional resignation option: although one month's notice and termination-payment language appears, the ad specifically says the employee must serve the full unexpired notice rather than automatically buying it out. Applicants currently engaged on a short contractual assignment should evaluate this exit constraint before accepting the offer.

## What the ICMR approval adds—and what it does not prove about personal duties

The ICMR Clinical Care Excellence Initiative multi-centre trial shortlist names **PERFUSE-AKI INDIA** and Dr Prasanta Kumar Das. That independent governmental project record explains the clinical-evidence context: evaluating a low-cost multimodal perfusion-guided strategy to reduce acute kidney injury in critically ill patients. It does **not** itself impose additional degree requirements, certify a post-specific day-to-day duty roster, guarantee the trial outcome or create an examination syllabus. Candidates with relevant experience in study monitoring, documentation and data workflows can connect their evidence to this trial purpose, but should not claim that every staff member is required to administer a particular intervention. ICMR project confirmation: https://www.icmr.gov.in/icmrobject/uploads/Call/1789363466_results_eoiforicmrclinicalcareexcellenceinitiativemulti-centreclinicaltrials.pdf.

## Candidate decision checklist and source records

Before committing to the six-month term, answer four concrete questions: (1) for Scientist-II, which of the two actual eligibility routes can you document; for PTS-II, can you prove all three elements including five years after the qualifying diploma? (2) Is the complete signed prescribed form going to **the correct principal investigator** before 5 PM on 23 October? (3) Are you currently in excluded regular government time-scale service? (4) Can you attend the offline interview after its date is confirmed and produce originals? The official 8-page advertisement and form is https://aiimsbhubaneswar.nic.in/wp-content/uploads/2026/10/Recruitment-Notice.pdf; AIIMS recruitment list is https://aiimsbhubaneswar.nic.in/category_recrutimentnotice/research-project-recruitment/. There is no officially specified application fee in this advertisement; that is an absence of a fee schedule, not an independently authenticated zero-fee declaration.